e-learning
resources
Berlin 2008
Monday, 06.10.2008
Malignant pleural mesothelioma: new aspects in treatment and aetiology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New seromarkers of mesothelioma: what do they mean in clinical practice?
B. Robinson (Perth, Australia)
Source:
Annual Congress 2008 - Malignant pleural mesothelioma: new aspects in treatment and aetiology
Session:
Malignant pleural mesothelioma: new aspects in treatment and aetiology
Session type:
Symposium
Number:
2718
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Robinson (Perth, Australia). New seromarkers of mesothelioma: what do they mean in clinical practice?. Annual Congress 2008 - Malignant pleural mesothelioma: new aspects in treatment and aetiology
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Immunotherapy for malignant pleural mesothelioma: ready for clinical practice?
Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies?
Year: 2016
From the guidelines to the clinical practice mesothelioma
Source: ERS Course 2019 - Thoracoscopy and Pleural Techniques, April 2019
Year: 2019
Current diagnostic practice for occupational asthma in the UK. Patient versus physician
Source: Eur Respir J 2004; 24: Suppl. 48, 367s
Year: 2004
Lung cancer screening - what does it mean for our practice?
Source: Virtual Congress 2020 – Screening and imaging in lung cancer
Year: 2020
Patient involvement in clinical research: a new golden standard
Source: Annual Congress 2011 - The value of patients as partners in research
Year: 2011
Malignant pleural mesothelioma: Current status and future projections in Turkey
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
Quality evaluation of primary care referrals to lung cancer services and their response in South London: Clinical practice in a pragmatic setting.
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018
Experience of hydroxychloroquine in the treatment of pulmonary sarcoidosis in the west of Ireland: An insight into clinical practice
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Awareness of GPs in Ukraine in Ukrainian guidelines in diagnostic and treatment of COPD: realities and reasons
Source: Eur Respir J 2004; 24: Suppl. 48, 84s
Year: 2004
Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances?
Source: Eur Respir J 2016; 47: 388-389
Year: 2016
Assessment of German national lung cancer guideline quality indicators in routine practice – Does the new TNM-system make a difference?
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011
Guidelines versus clinical practice in the treatment of COPD: a reappraisal
Source: Eur Respir J 2006; 27: 656
Year: 2006
Rational monitoring of COPD: where do current clinical guidelines stand?
Source: Eur Respir J 2007; 29: 1078-1081
Year: 2007
Late Breaking Abstract: The ERS recommendations on smoking cessation: Can they be used in clinical practice? The
ICEBERG
project (
I
mplementation of smoking
CE
ssation in respiratory
P
atients according to the
ER
S
G
uidelines)
Source: Annual Congress 2010 - Education for smoking control
Year: 2010
A registry of patients with idiopathic pulmonary fibrosis in Russia: 2-yr results and therapeutic modalities in real-life practice
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019
Current practice: safety checklists for pleural procedures
Source: International Congress 2017 – Pleural interventions and transthoracic ultrasound (TUS)
Year: 2017
Molecular diagnosis of tuberculosis in a north Italian clinical setting: results of routine use of a commercial LCR-based test
Source: Eur Respir J 2001; 18: Suppl. 33, 360s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept